New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novo Nordisk A/S

NVO

Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.

Revenue
+3.87%
EPS
−17.1%
Free cash flow
−14.8%
Total debt
+30.7%

Quarter to September 2026, against a year earlier

38.52 0.37 −0.95%
Market cap
$128.6B
P/E
9.8×
Fwd P/E FY26e
—
Dividend yield
4.62%
F-score
5/9
ROIC
29.6%
Net debt / EBITDA
0.7×
Payout ratio
0.5×

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 29.6% in Q3 FY26, the highest of these four quarters.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE61.8%74.1%60.8%58.8%
ROIC27.4%28.6%28.7%29.6%

Debt

Net debt is 2.30× a year’s EBITDA. Debt is 0.62× equity, against 0.72× in Q1 FY26.

Debt / equityNet debt / EBITDA
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Debt / equity0.7×0.7×0.6×0.6×
Net debt / EBITDA2.5×1.9×2.4×2.3×

Cash cycle, in days

Customers pay in 120 days, inventory is held 290 days and suppliers are paid in 86. Cash is tied up for 324 days between paying for goods and being paid.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Cash cycle291339330324
Days to pay suppliers123928486
Days to be paid105113120120

Per share, from Q4 FY25

Since Q4 FY25, per share: free cash flow has grown 58.1%; revenue has grown 11.9%; book value has grown 15.1%.

Free cash flowRevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Free cash flow1.0×1.1×1.7×1.6×
Revenue1.0×1.1×1.1×1.1×
Book value1.0×1.1×1.2×1.2×
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

14.66 8.63 11.72 9.55
P/S ratio
4.83 3.20 4.13 3.22
P/FCF ratio
51.51 33.56 27.94 24.28
P/Operating CF
393.97 43.28 24.83 26.52
P/B ratio
7.69 5.13 6.18 4.98
EV/Sales
5.15 3.58 4.41 3.47
EV/EBITDA
10.63 6.86 8.57 6.61
EV/FCF
54.86 37.45 29.81 26.19
Current Ratio
0.80 0.79 0.87 0.84
Net Debt/EBITDA
2.53 1.91 2.44 2.30
Debt/Equity
0.67 0.72 0.63 0.62
Earnings Yield
6.82% 11.59% 8.53% 10.47%
Free Cash Flow Yield
1.94% 2.98% 3.58% 4.12%
Free Cash Flow per Share
(1.31) 0.42 1.48 0.96
Book value per Share
6.61 7.16 7.76 7.61
Free Cash Flow
(5,822.49) 1,886.25 6,585.08 4,229.67
EV/EBIT
12.46 7.85 10.17 8.13
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 18, 2026